Two leading health systems are taking markedly different approaches to cutting clinical variation, which can hinder care quality and drive up costs when left unchecked. Variation in clinical care ...

Gain insights into Chemed Corporation's Q1 2025 performance, with VITAS growth, strategic Medicare Cap solutions, and Roto-Rooter's revenue recovery outlined.

Alzinova AB (publ) (ticker: ALZ) is pleased to announce the release of the drug substance for its upcoming Phase 2 clinical trial of the vaccine candidate ALZ-101 in early Alzheimer's disease. This mi ...

ACTO, the only AI-powered Intelligent Field Excellence (IFE) platform purpose-built for the life sciences industry, and ScienceMedia, the pioneer in scientifically validated clinical training, today ...